Comments
By submitting this form, you agree to receive communications regarding offerings that are associated with this organization. You are granting MIT Professional Education, 700 Technology Square, Building NE48-200, Cambridge, Massachusetts, 02139, United States permission to email you. You may unsubscribe or update your email preferences via the link found at the bottom of every email. View our privacy policy.
is a MIT Professional Short Program that’ll help engineers, physicians, and biotechnology professionals bring these life-changing therapies from the lab and into the hands of patients in need.
Lead by MIT Professor Anthony J. Sinskey, Executive Director of the MIT Center for Biomedical Innovation Stacy Springs, and BioMAN Director Jackie Wolfrum
Innovative clinical trial cell therapy models for evidence generation
GMP environment and the manufacturing platforms needed to obtain, genetically modify, and produce cell therapy products
Cell therapy product development roadmap
Scientific, medical, and engineering principles to avoid major delays in cell therapy manufacturing and clinical and biomarker development
